Search for:
Main
Current issue
Archive
Authors
Subscription
Info
Reviews
Original contributions
Short communications
Lectures
Letter to editor
Technical advance
Editorial
Chronicle
Information
Ukrainian Medical Journal Online
Допомога хворим на COVID-19 на Львівщині
Еволюція SARS-CoV-2: нові докази ролі імунореактивності макроорганізму
COVID-19: хто отримає щеплення вакциною Pfizer
Вакцинація від COVID-19: в Україну прибула вакцина...
More
Keyword : doxorubicin
Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma
Authors :Yushko L.A.* Sarnatskaya V.V. Sakhno L.A. Hudenko N.V.... Date: 2021-03-25 / Views: 107
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
Authors :Boroday N.V. * Chekhun V.F. Date: 2018-03-29 / Views: 329
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
Authors :Yalovenko T.M. Todor I.M. Lukianova N.Y.* Chekhun V.F. Vol. 38, No. 2 / Views: 542
Zinc differentially modulates DNA damage induced by anthracyclines in normal and cancer cells
Authors :Wysokinski D. Blasiak J. Wozniak K. Date: 2012-12-25 / Views: 487
Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
Authors :Zykova M.G. Medvedeva N.V. Torkhovskaya T.I. Tikhonova E.G.... Date: 2012-12-24 / Views: 325
COMBINATION OF CYCLOOXYGENASE-2 INHIBITOR AND DOXORUBICIN INCREASES THE GROWTH INHIBITION AND APOPTOSIS IN HUMAN HEPATOCELLULAR CARCINOMA CELLS
Authors :Pan Y.Y. Xu S.P. Jia X.Y. Xu H.Q.... Vol. 29, No. 1 / Views: 86
Efficacy of different immunotherapy approaches toward treatment ofdoxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma
Authors :Belova O.B. Vinnichuk U.D. Shlyakhovenko V.O.* Berezhnaya N.M. Vol. 29, No. 4 / Views: 81
TOTAL PROTEOLYTIC ACTIVITY AND CONTENT OF THE MAIN PROTEINASE INHIBITORS IN BLOOD PLASMA OF RATS BEARING DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT GUERIN CARCINOMA
Authors :Chekhun Vasyl F. Kovtonyuk Oksana V. Todor I.N. Kulik Galina I.... Vol. 26, No. 3 / Views: 53
COMPARATIVE ANALYSIS OF APOPTOSIS INDUCED BY VARIOUS ANTICANCER DRUGS IN JURKAT CELLS
Authors :Sokolovskaya A.A. Zabotina T.N. Blokhin D.Yu. Kadagidze Z.G.... Vol. 23, No. 1 / Views: 241
EFFECTS OF MECHANOCHEMICALLY ACTIVATED DOXORUBICIN AND 40 MHz FREQUENCY IRRADIATION ON HUMAN A-549 LUNG CARCINOMA CELLS
Authors :Orel V.E.* Kudryavets Yu.I. Satz S. Bezdenezhnih N.A.... Vol. 26, No. 4 / Views: 101
The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and В16 melanoma resistant to doxorubicin
Authors :Berezhnaya N.M. Vinnichuk Yu.D. Belova O.B. Vol. 30, No. 1 / Views: 98
Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin
Authors :Lukyanova N.Yu. Rusetskya N.V. Tregubova N.A. Chekhun V.F. Vol. 31, No. 2 / Views: 490
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
Authors :Rusetskaya N.V. Lukyanova N.Yu. Chekhun V.F. Vol. 31, No. 3 / Views: 262
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
Author :Lukyanova N.Yu. Vol. 32, No. 1 / Views: 148
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
Authors :Yurchenko O.V. Rusetskya N.V. Naleskina L.A. Chekhun V.F. Vol. 32, No. 1 / Views: 83